Search research articles
Contact Us
Filters
Showing results (31-40 of 195) with videos related to
Page
of 20
Sort By:
Leukemia
|
September 7, 2007
Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping
C Haferlach, F Dicker, S Schnittger, et al.
Leukemia
|
May 8, 2013
SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis
M Meggendorfer, W Kern, C Haferlach, et al.
Methods of Information in Medicine
|
March 16, 2006
A generic concept for large-scale microarray analysis dedicated to medical diagnostics
M Dugas, F Weninger, S Merk, et al.
Leukemia
|
June 9, 2017
MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations
A Stengel, W Kern, M Meggendorfer, et al.
Leukemia
|
February 9, 2007
Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients
S Schnittger, U Bacher, C Haferlach, et al.
Annals of Hematology
|
January 5, 2002
New insights into the biology of multiple myeloma using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level
C Nickenig, N K Lang, C Schoch, et al.
Infusionstherapie Und Transfusionsmedizin
|
February 1, 1996
Can blood group O red cells of donor origin acquire weak group A reactivity through serum A transferase of the recipient after bone marrow transplantation?
M G Wichmann, T Haferlach, M Suttorp, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine
|
January 1, 1994
Can blood group O red cells of donor origin acquire weak group A reactivity through serum A transferase of the recipient after bone marrow transplantation?
M G Wichmann, T Haferlach, M Suttorp, et al.
Leukemia
|
June 6, 2008
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype
C Haferlach, F Dicker, H Herholz, et al.
Leukemia
|
July 28, 2006
Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E
S Schnittger, U Bacher, W Kern, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 195) with videos related to
Sort By:
Page
of 20
Leukemia
|
September 7, 2007
Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping
C Haferlach, F Dicker, S Schnittger, et al.
Leukemia
|
May 8, 2013
SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis
M Meggendorfer, W Kern, C Haferlach, et al.
Methods of Information in Medicine
|
March 16, 2006
A generic concept for large-scale microarray analysis dedicated to medical diagnostics
M Dugas, F Weninger, S Merk, et al.
Leukemia
|
June 9, 2017
MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations
A Stengel, W Kern, M Meggendorfer, et al.
Leukemia
|
February 9, 2007
Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients
S Schnittger, U Bacher, C Haferlach, et al.
Annals of Hematology
|
January 5, 2002
New insights into the biology of multiple myeloma using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level
C Nickenig, N K Lang, C Schoch, et al.
Infusionstherapie Und Transfusionsmedizin
|
February 1, 1996
Can blood group O red cells of donor origin acquire weak group A reactivity through serum A transferase of the recipient after bone marrow transplantation?
M G Wichmann, T Haferlach, M Suttorp, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine
|
January 1, 1994
Can blood group O red cells of donor origin acquire weak group A reactivity through serum A transferase of the recipient after bone marrow transplantation?
M G Wichmann, T Haferlach, M Suttorp, et al.
Leukemia
|
June 6, 2008
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype
C Haferlach, F Dicker, H Herholz, et al.
Leukemia
|
July 28, 2006
Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E
S Schnittger, U Bacher, W Kern, et al.
Page
of 20